Medifocus Inc (MFS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Medifocus Inc (MFS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9446
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medifocus Inc (Medifocus) is a medical technology company. The company develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate. Its technology platforms includes endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and adaptive phased array (APA) microwave focusing platform, which directs microwave energy at tumor center to induce shrinkage and eradication of tumors without undue harm to surrounding tissue. The company develops heat-activated and tumor-targeted immunotherapy and gene therapy technology for the treatment of cancers and other diseases; and APA 1000, a minimally invasive breast cancer treatment system, which is in pivotal Phase-III clinical trials. It has operations in Canada and the US. Medifocus is headquartered in Toronto, Ontario, Canada.

Medifocus Inc (MFS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medifocus Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Medifocus Inc, Medical Devices Deals, 2012 to YTD 2018 9
Medifocus Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Medifocus Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Medifocus Enters into R&D and Manufacturing Agreement with Yuanxing Bio-Pharm 11
Medifocus To Form Joint Venture With Ideal Concept 12
Licensing Agreements 13
Medifocus Enters into Licensing Agreement with Duke University 13
Equity Offering 14
Medifocus Raises USD1.8 Million in Private Placement of Shares 14
Medifocus Raises USD1.6 Million in Private Placement of Units 15
Medifocus Completes Second Tranche Of Private Placement Of Units For US$5.3 Million 16
Medifocus Completes Private Placement Of Units For US$2 Million 18
Medifocus Inc – Key Competitors 19
Medifocus Inc – Key Employees 20
Medifocus Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Aug 28, 2017: Medifocus Announces Significant Improvement in Operating Results for the Fiscal Year Ending March 31, 2017 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Medifocus Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medifocus Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medifocus Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Medifocus Inc, Medical Devices Deals, 2012 to YTD 2018 9
Medifocus Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Medifocus Enters into R&D and Manufacturing Agreement with Yuanxing Bio-Pharm 11
Medifocus To Form Joint Venture With Ideal Concept 12
Medifocus Enters into Licensing Agreement with Duke University 13
Medifocus Raises USD1.8 Million in Private Placement of Shares 14
Medifocus Raises USD1.6 Million in Private Placement of Units 15
Medifocus Completes Second Tranche Of Private Placement Of Units For US$5.3 Million 16
Medifocus Completes Private Placement Of Units For US$2 Million 18
Medifocus Inc, Key Competitors 19
Medifocus Inc, Key Employees 20
Medifocus Inc, Other Locations 21

List of Figures
Medifocus Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medifocus Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Medifocus Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Medifocus Inc (MFS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TUI Group:企業の戦略・SWOT・財務情報
    TUI Group - Strategy, SWOT and Corporate Finance Report Summary TUI Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Galadari Hotels (Lanka) PLC :企業の戦略・SWOT・財務情報
    Galadari Hotels (Lanka) PLC - Strategy, SWOT and Corporate Finance Report Summary Galadari Hotels (Lanka) PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Valeo Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Valeo Pharma Inc (Valeo Pharma), a subsidiary of Manitex Capital Inc, is a pharmaceutical company that offers healthcare solutions and specialty products. The company provides dermatology products such as drops, tablets, solutions, injections among others. It develops, licenses, and commerci …
  • Biolase, Inc. (BIOL)-医療機器分野:企業M&A・提携分析
    Summary Biolase, Inc. (Biolase) is medical device company which develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser s …
  • Fagron NV (FAGR):企業の財務・戦略的SWOT分析
    Summary Fagron NV (Fagron), formerly Arseus NV is a pharmaceutical compounding solution provider. The company offers products such as raw materials, extracts and tinctures, flammable products, anesthesia, ointment bases, syrups, suspension media, triturations, phyto pharmaflore, medispend, capsicard …
  • Armune BioScience Inc:医療機器:M&Aディール及び事業提携情報
    Summary Armune BioScience Inc (Armune BioScience), a subsidiary of Exact Sciences Corp is a medical device development company that develops and commercializes molecular prognostic and diagnostic tests. The company uses genomics and proteomics in cancer to identifying specific sets of genes or prote …
  • New World Development Company Limited:企業の戦略・SWOT・財務分析
    New World Development Company Limited - Strategy, SWOT and Corporate Finance Report Summary New World Development Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Orbis S.A.:企業の戦略・SWOT・財務情報
    Orbis S.A. - Strategy, SWOT and Corporate Finance Report Summary Orbis S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Nichirei Corporation:企業の戦略・SWOT・財務情報
    Nichirei Corporation - Strategy, SWOT and Corporate Finance Report Summary Nichirei Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Nasdaq Inc (NDAQ):企業の財務・戦略的SWOT分析
    Nasdaq Inc (NDAQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kaneka Corp (4118):医療機器:M&Aディール及び事業提携情報
    Summary Kaneka Corp (Kaneka) is a chemical manufacturing company. Its product offerings include polyvinyl chloride, caustic soda, hydrochloric acid, flexible PVC compounds, rigid PVC compounds, paste PVC and chlorinated PVC. Its products include functional plastics, expandable plastics and products, …
  • Magna International Inc.:企業の戦略・SWOT・財務情報
    Magna International Inc. - Strategy, SWOT and Corporate Finance Report Summary Magna International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Astex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Astex Pharmaceuticals Inc (Astex Pharmaceuticals), is a novel drug discovery and development company with a focus on cancer and central nervous system (CNS) diseases. It discovers and develops small molecule treatments. The company’s lead product, Dacogen (indicated for the treatment of myel …
  • Medifocus Inc (MFS):製薬・医療:M&Aディール及び事業提携情報
    Summary Medifocus Inc (Medifocus) is a medical technology company. The company develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate. Its technology platforms includes endo-thermotherapy platform, a catheter-based …
  • Panasonic Corporation (6752):企業の財務・戦略的SWOT分析
    Panasonic Corporation (6752) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Fortive Corporation:戦略・SWOT・企業財務分析
    Fortive Corporation - Strategy, SWOT and Corporate Finance Report Summary Fortive Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • MediGene AG (MDG1):製薬・医療:M&Aディール及び事業提携情報
    Summary MediGene AG (MediGene) is a biotechnology company which develops drugs for the treatment of various types and stages of cancer with candidates in clinical and pre-clinical development. The company focuses on the development of personalized T-cell-based immunotherapies. Its core business deve …
  • Westinghouse Electric Company LLC-エネルギー分野:企業M&A・提携分析
    Summary Westinghouse Electric Company, LLC (Westinghouse), a subsidiary of Toshiba Corporation, is a nuclear energy company. It offers nuclear plant products, technologies, nuclear fuel, plant design and related services to utilities across the world. The company conducts the development, licensing, …
  • Formosa Chemicals & Fibre Corp (1326):企業の財務・戦略的SWOT分析
    Formosa Chemicals & Fibre Corp (1326) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Intercede Group plc (IGP):企業の財務・戦略的SWOT分析
    Intercede Group plc (IGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆